Here's Why TransEnterix Fell Hard on Thursday
Shares of TransEnterix (NYSEMKT: TRXC), a medical device company marketing the Senhance robot-assisted surgical system, are plunging again in response to a dismal second-quarter earnings report. Investors disturbed by a lack of new system sales drove the stock 21.7% lower on Thursday.
In 2018 Transenterix sold an encouraging 15 Senhance robots. Now it looks like the party's over before it ever kicked into high gear.
Image source: Getty Images.
Quelle Fool.com


